Search
for
Sort by
Research 61–90 of 1000+
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility
- Editor’s picks January 2021
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- Author Response: Touch receptor end-organ innervation and function require sensory neuron expression of the transcription factor Meis2
- Insights About a Pandemic: Clinical Approach
- Abstract #1182315: Biotin and thyroid function test
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- TELECONSULTA EM INSUFICIÊNCIA CARDÍACA: REVISÃO DE ESCOPO
- TRANSTORNOS DISSOCIATIVOS EM PACIENTES VÍTIMAS DE ABUSO SEXUAL NA INFÂNCIA
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- International Journal of KIU
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- The Physiological Impact of Melatonin, Its Effect on the Course of Diseases and Their Therapy and the Effect of Magnetic Fields on Melatonin Secretion—Potential Common Pathways of Influence
- The JAK/STAT signaling pathway: from bench to clinic
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Time of onset and duration of post-COVID-19 acute telogen effluvium
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Recommendations on trichological treatments during COVID-19 pandemic
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- ALOPÉCIA COMO MANIFESTAÇÃO PÓS-COVID-19: IMPLICAÇÕES CLÍNICAS, FATORES DE RISCO E ESTRATÉGIAS FISIOTERAPÊUTICAS PARA REABILITAÇÃO CAPILAR
- Is COVID-19 Gender-sensitive?